Cohen & Steers, Inc. (New York Stock Exchange:CNS)
| Market Cap | 3.76B+6.9% |
| Revenue (ttm) | 613.48M+7.9% |
| Net Income | 168.83M+2.8% |
| EPS | 3.26+2.2% |
| Shares Out | 51.43M |
| PE Ratio | 22.32 |
| Forward PE | 20.68 |
| Dividend | $2.63(3.59%) |
| Ex-Dividend Date | Nov 9, 2026 |
| Volume | 188,798 |
| Open | 73.40 |
| Previous Close | 73.23 |
| Day's Range | 71.97 - 73.72 |
| 52-Week Range | 58.39 - 86.56 |
| Beta | 1.18 |
| Analysts | Sell |
| Price Target | 88.00(+20.22%) |
| Earnings Date | Jan 28, 2027 |
Insiders here have filed 17 Form 4s in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
About CNS
Cohen & Steers, Inc. operates as a publicly traded holding company specializing in asset management. Through its various operating units, the firm delivers financial services to institutional investors, such as pension funds, university endowments, and charitable foundations. Its subsidiaries are tasked with managing bespoke client portfolios across equities, fixed income, multi-asset strategies, and commodities. Additionally, these subsidiaries develop and oversee a diverse range of investment vehicles, including mutual funds (focused on equity, fixed income, balanced, and multi-asset classes) and hedge funds. The company's global investment strategy, implemented via its affiliated entities, involves allocating capital in public equity, fixed income, and commodity markets. For its equity and fixed income allocations, the firm's affiliates specifically target businesses within the real estate industry (including REITs), infrastructure, and natural energy resources. Preferred securities also constitute a part of its fixed income portfolios. Established in 1986, Cohen & Steers, Inc. maintains its primary base in New York, with international branch offices in London (UK), Central (Hong Kong), Tokyo (Japan), and Seattle (Washington).
What Are Insiders Doing?
View the trades behind this meter — each links to its SEC Form 4 →
Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.
Analyst consensus
1 firm rating CNS in the last 3 months, one vote each. Issuer-paid research is not counted.
Next catalysts
- Nov 9, 2026Ex-dividend date
- Jan 28, 2027Earnings report
Ask Barron about CNS
$CNS stock is featured in our Congress Trading, and Insider Trades datasets.
→ All Stock ListsCongress Trading
Recent trades of CNS by members of U.S. Congress
| Politician | Type | Traded |
|---|---|---|
| Gilbert CisnerosHouse / D | Purchase$1.00K – $15.00K | Oct 30, 2025 |
| Gilbert Ray CisnerosHouse / D | Purchase$1.00K – $15.00K | Oct 30, 2025 |
| Gilbert Ray CisnerosHouse / D | Purchase$1.00K – $15.00K | Oct 29, 2025 |
| Josh GottheimerHouse / D | Sale$1.00K – $15.00K | Sep 25, 2024 |
| Gilbert Ray CisnerosHouse / D | Purchase$1.00K – $15.00K | Nov 13, 2020 |
| Gilbert CisnerosHouse / D | Purchase$1.00K – $15.00K | Nov 13, 2020 |
| Gilbert Ray CisnerosHouse / D | Purchase$1.00K – $15.00K | Nov 12, 2020 |
| Gilbert Ray CisnerosHouse / D | Sale$1.00K – $15.00K | Dec 12, 2019 |
Recently reported changes in CNS holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by CNS's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
CNS Estimated quarterly lobbying spending
Source: U.S. Senate LDA
CNS Revenue by Segment or Geography
| Segment | Revenue | % of All |
|---|---|---|
| Open-end funds | $92.53M | 58.78% |
| Institutional | $36.57M | 23.23% |
| Closed-end funds | $28.32M | 17.99% |
As of: Q3 2026 (Sep 30, 2026) · Source: SEC EDGAR (10-Q)
U.S. Patents
New CNS patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to CNS from public contracts
Source: USAspending.gov
Top ETF Holders
ETFs with the largest estimated holdings in CNS
| ETF | Est. Holding Size |
|---|---|
| IJRiShares Core S&P Small-Cap ETF | $125.59M |
| VTIVanguard Morningstar Total Stock Market ETF | $66.06M |
| SCHDSchwab U.S. Dividend Equity ETF | $59.05M |
| IWMiShares Russell 2000 ETF | $58.02M |
| VBVanguard Morningstar Small-Cap ETF | $46.56M |
| DFASDimensional - US Small Cap ETF | $31.86M |
Estimated from each fund’s disclosed top holdings × AUM
CNS Insider Score
Our composite score: insider buying, sector, volume, tone & dilution
Bull Case vs Bear Case
AI-generated from CNS’s recent data — informational, not investment advice
What’s Behind the Score
News check: Mix of routine dividend and fund distribution disclosures; one opinion piece suggesting alternatives does not outweigh routine corporate actions.